Image

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Study on Medication for Women Aged 18-49

Recruiting
18-49 years
All
Phase 1

This study investigates an investigational medication for adult females aged 18 to 49 years. The purpose of this study is to understand the effects and safety of the investigational medication in this population. Participants will be selected based on specific criteria, including age and reproductive status, to ensure the study results are reliable.

Participants will undergo various procedures, including regular health assessments and monitoring. The study will evaluate the effects of the investigational medication by comparing it to a placebo, an inactive substance that looks like the investigational medication but does not contain any medicine. This comparison helps researchers understand the medication's true effects.

  • Who can participate: Women aged 18 to 49 years who are not pregnant or breastfeeding can participate. They must be of non-childbearing potential or agree to use effective contraception. Participants should not have any medical condition that might interfere with the study.
  • Study details: Participants will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. Participants must agree to follow all study procedures and use effective contraception if of childbearing potential.
  • Study Timelines: The study will last approximately 6 months.
Study details
    Healthy Volunteers
    Influenza Vaccination
    Respiratory Syncytial Virus Vaccination
    Parainfluenza Vaccination
    Human Metapneumovirus Vaccination

NCT06850051

Sanofi

8 May 2025

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
This helps us to contact you based on your preferred way of contact
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.